Chiesi Farmaceutici S.p.a.

Alessandra Ferraris

Gaetano Brambilla

David Andrew Lewis

David Ganderton

Brian John Meakin

Tanya Kathleen Church

Brian Meakin

Rebecca Jaine Davies

A metal container and a method of preparing a metal container for a pharmaceutical formulation where the active ingredient is formoterol, a stereoisomer of formoterol, and a physiologically acceptable salt of formoterol, in a solution of a liquefied HFA propellant.

Formoterol superfine formulation

An aerosol solution composition for use in an aerosol inhaler comprises an active material, a propellant containing a hydrofluoroalkane, a cosolvent and optionally a low volatility component to increase the mass median aerodynamic diameter (MMAD) of the aerosol particles on actuation of the inhaler. The composition is stabilized by using a small amount of mineral acid and a suitable can having part or all of its internal metallic surfaces made of stainless steel, anodized aluminium or lined with an inert organic coating.

Stable pharmaceutical solution formulations for pressurized metered dose inhalers

Formulations for the administration through pressurized metered dose aerosol inhalers containing an anticholineric drug in solution in a hydrofluorocarbon propellant, a cosolvent and a low volatility component, and the use thereof in chronic obstructive pulmonary disease.

Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease

Growing community of inventors

Parma, Italy

Alessandra Ferraris